Foundation’s Executive Director Represents the APBD Community at NORD’s 2025 Breakthrough Summit 

Written By Gabriel Baril

Oct. 24, 2025

Over 900 rare disease advocates, clinicians, researchers, industry partners, and other leaders gathered earlier this month in Washington, DC for the National Organization for Rare Disease’s (NORD) 2025 Breakthrough Summit.

From left to right: Rare advocates Donna Appell (HPS Network), Karen Bly (NOAH), Ashley Appell (HPS Network), Natacha Pires (APBDRF), and Julie Raskin (CHI)
Photo Credit: Julie Raskin


Natacha Pires, MS, MBBS, our Foundation's Executive Director, who attended the event shared, “This year’s Summit served as an encouraging reminder of the power of finding patients and families, the importance of collaboration in advancing research, and the value of getting the next generation of advocates involved early.” 

The APBD Research Foundation is proud to partner with NORD in our commitment to the GSD IV and broader rare community.

 

News Releases

Featured
Historic Milestone: APBD Community Raises Over $200,000 to Advance Research
Historic Milestone: APBD Community Raises Over $200,000 to Advance Research

We are thrilled to announce that our community raised an incredible $201,177 during the 2026 APBD Tour de Friends Rally for Research fundraising campaign, exceeding our original goal of $120,000.

Read more →
Dr. Jeff Levenson, APBDRF's Co-President, Receives the Academy of General Dentistry's Lifelong Learning & Service Recognition
Dr. Jeff Levenson, APBDRF's Co-President, Receives the Academy of General Dentistry's Lifelong Learning & Service Recognition

The Academy of General Dentistry (AGD) recently awarded the APBD Research Foundation's co-president Dr. Jeff Levenson with the Lifelong Learning & Service Recognition (LLSR). He received this award along with 36 other LLSR recipients during the AGD’s scientific session in Las Vegas, NV on June 27, 2026.

Read more →
Foundation Launches Drug Repurposing Initiative in Partnership with COMBINEDBrain
Foundation Launches Drug Repurposing Initiative in Partnership with COMBINEDBrain

In April 2026, the APBD Research Foundation announced participant recruitment for its APBDRF Drug Repurposing Study initiative in partnership with COMBINEDBrain. We are grateful to the patients and families in our community that have volunteered to provide biosamples to help make this study a reality.

Read more →
APBD Research Foundation 2025 Rally for Research Grant Series:  Duke University Scientist Awarded Pilot Grant to Evaluate Gene Replacement Therapy for APBD and Other Forms of GSD IV
APBD Research Foundation 2025 Rally for Research Grant Series:  Duke University Scientist Awarded Pilot Grant to Evaluate Gene Replacement Therapy for APBD and Other Forms of GSD IV

The APBD Research Foundation is pleased to announce the third of our 2025 Rally for Research Pilot Grant Program grant recipients: Rebecca Koch, PhD, RDN at Duke University. Her research project is entitled, Gene Therapy to Treat the Neurophenotype of Glycogen Storage Disease Type IV.

Read more →
APBD Research Foundation 2025 Rally for Research Grant Series:  UTSW Medical Center Scientist Awarded Pilot Grant to Evaluate Treatment for an Allied Disease in APBD
APBD Research Foundation 2025 Rally for Research Grant Series:  UTSW Medical Center Scientist Awarded Pilot Grant to Evaluate Treatment for an Allied Disease in APBD

The APBD Research Foundation is pleased to announce the second of our 2025 Rally for Research Pilot Grant Program grant recipients: Mayank Verma, MD, PhD at UTSW Medical Center. His research project is entitled Preclinical Validation and Biomarkers in APBD of a GYS1-ASO Currently in Phase 1 Clinical Trial for Lafora Disease

Read more →
Foundation Submits Public Comment to the FDA on the Plausible Mechanism Framework for Accelerating Individualized Therapy Development for Rare Diseases
Foundation Submits Public Comment to the FDA on the Plausible Mechanism Framework for Accelerating Individualized Therapy Development for Rare Diseases

On behalf of the APBD community, the APBD Research Foundation has responded to the US Food and Drug Administration's (FDA) request for public comments for its recently released draft guidance for the use of the Plausible Mechanism Framework for individualized genetic therapies. 

Read more →
JUST PUBLISHED: New Study Highlights That Over 34,000 People Worldwide Are Affected by APBD and Other Forms of GSD IV
JUST PUBLISHED: New Study Highlights That Over 34,000 People Worldwide Are Affected by APBD and Other Forms of GSD IV

We are excited to share that our global genetic prevalence of GBE1-related diseases study has been published in the Journal of Inherited Metabolic Disease Reports (JIMD Reports).

Read more →
Advancing APBD Research Has Never Been More Urgent or More Promising
Advancing APBD Research Has Never Been More Urgent or More Promising

We are excited to launch the 2026 APBD Tour de Friends Rally for Research Fundraising Campaign to raise $150,000.

Read more →
We Need You for the APBDRF Drug Repurposing Study!
We Need You for the APBDRF Drug Repurposing Study!

The APBD Research Foundation is excited to announce an opportunity for you to play a direct role in advancing treatment research. You do not have to leave home to participate.

Read more →
Carol Rosenstock Joins the APBD Research Foundation’s Board of Directors
Carol Rosenstock Joins the APBD Research Foundation’s Board of Directors

The APBD Research Foundation is delighted to announce the appointment of Carol Rosenstock to its Board of Directors.

Read more →
Summary Block
This block has no content yet. Items you add to the page connected to this block will display here.
Featured
Gabriel Baril
Previous

Foundation Attends n-Lorem Foundation’s Third Annual Nano-rare Patient Colloquium
Next

Participate in the Living Rare Study: Share Your Experience, Help Shape the Future